"For 65 years, Hoag Memorial Hospital Presbyterian has stood on the bluffs in Newport Beach, CA, as a beacon of exceptional health care. A place where the best and brightest physicians care for their patients with the support of highly skilled nurses and a wide range of dedicated staff. Hoag Hospital Newport Beach is an acute care, nonprofit hospital located on California's Orange County coastline between Los Angeles and San Diego in Newport Beach. Hoag offers a comprehensive mix of health care services including institutes specializing in care for cancer, heart and vascular, neurosciences and women’s health, and orthopedics through Hoag’s affiliate, Hoag Orthopedic Institute."

During the past decade, Hoag Memorial Hospital Presbyterian conducted 128 clinical trials. In the 10-year time frame, 128 clinical trials started and 51 clinical trials were completed, i.e. on average, 39.8% percent of trials that started reached the finish line to date. In the past 5 years, 73 clinical trials started and 30 clinical trials were completed. i.e. 41.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hoag Memorial Hospital Presbyterian" #1 sponsor was "Hoag Memorial Hospital Presbyterian" with 18 trials, followed by "University of Southern California" with 13 trials sponsored, "Pfizer" with 8 trials sponsored, "ImmunityBio, Inc." with 6 trials sponsored and "Abbott Medical Devices" with 6 trials sponsored. Other sponsors include 141 different institutions and companies that sponsored additional 110 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hoag Memorial Hospital Presbyterian" #1 collaborator was "National Cancer Institute (NCI)" with 14 trials as a collaborator, "Cancer Biotherapy Research Group" with 8 trials as a collaborator, "Hoag Memorial Hospital Presbyterian" with 5 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 4 trials as a collaborator and "National Institute on Aging (NIA)" with 4 trials as a collaborator. Other collaborators include 99 different institutions and companies that were collaborators in the rest 98 trials.

According to Clinical.Site data, the most researched conditions in "Hoag Memorial Hospital Presbyterian" are "COVID-19" (11 trials), "Breast Cancer" (8 trials), "Atrial Fibrillation" (7 trials), "Stroke" (7 trials) and "Alzheimer Disease" (6 trials). Many other conditions were trialed in "Hoag Memorial Hospital Presbyterian" in a lesser frequency.

Most popular intervention types in "Hoag Memorial Hospital Presbyterian" are "Drug" (114 trials), "Device" (48 trials), "Biological" (42 trials), "Other" (27 trials) and "Procedure" (10 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (25 trials), "Remdesivir" (7 trials), "recombinant interferon alfa" (6 trials), "Pembrolizumab" (5 trials) and "rituximab" (5 trials). Other intervention names were less common.

The vast majority of trials in "Hoag Memorial Hospital Presbyterian" are 182 trials for "All" genders, 10 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Hoag Memorial Hospital Presbyterian". undefined are not yet recruiting, 54 are recruiting, 27 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 71 completed trials in Hoag Memorial Hospital Presbyterian, 2 suspended trials, and 23 terminated clinical trials to date.

Out of the total trials that were conducted in Hoag Memorial Hospital Presbyterian, 39 "Phase 1" clinical trials were conducted, 63 "Phase 2" clinical trials and 47 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 39 trials that are defined as “Not Applicable".